A simple risk score using routine data for predicting cardiovascular disease in primary care

British Journal of General Practice

Volumn 60, Issue 577, 2010, Pages

  Chamnan, Parinya ^a   Simmons, Rebecca K ^a   Hori, Hiroyuki ^b   Sharp, Stephen ^a   Khaw, Kay Tee ^c   Wareham, Nicholas J ^a   Grijfin, Simon J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cardiovascular disease; Diabetes; Prediction; Primary care; Risk assessment

Indexed keywords

ADULT; AGED; ARTICLE; CALIBRATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 78650578390     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X515098     Document Type: Article

References (25)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349(9061): 1269-1276.
2. Jackson R, Lawes CM, Bennett DA, et al. Treatment with drugs to lower blood pressure and blood cholesterol based on an individuals absolute cardiovascular risk. Lancet 2005; 365(9457): 434-441.
3. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91 Suppl 5: v1-52.
4. UK National Screening Committee. Handbook for vascular risk assessment, risk reduction and risk management. UK Screening Portal, 2008. http://www.library.nhs.uk/HealthManagement/ViewResource.aspx?resID=282009 (accessed 28 Feb 2010).
5. Jackson R. Cardiovascular risk prediction: are we there yet? Heart 2008; 94(1): 1-3.
6. Capewell S, Will screening individuals at high risk of cardiovascular events deliver large benefits? No. BMJ 2008; 337: a1395.
7. Brindle P, Emberson J, Lampe F, et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327(7426): 1267.
8. Shaw C, Abrams K, Marteau TM. Psychological impact of predicting individuals' risks of illness: a systematic review. Soc Sci Med 1999; 49(12): 1571-1598. (Pubitemid 29428059)
9. Stern MP. Diabetes and cardiovascular disease. The 'common soil' hypothesis. Diabetes 1995; 44(4): 369-374.
10. Griffin SJ, little PS, Hales CN, et al. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000; 16(3): 164-171.
11. Spijkerman AM, Yuyun MF, Griffin SJ, et al. The performance of a risk score as a screening test for undiagnosed hyperglycemia in ethnic minority groups: data from the 1999 health survey for England. Diabetes Care 2004; 27(1): 116-122.
12. Rahman M, Simmons RK, Harding AH, et al. A simple risk score identifies individuals at high risk of developing type 2 diabetes: a prospective cohort study. Fam Pract 2008; 25(3): 191-196.
13. Spijkerman A, Griffin S, Dekker J, et al. What is the risk of mortality for people who screen positive in a diabetes screening programme but who do not have diabetes on biochemical testing? Diabetes screening programmes from a public health perspective. J Med Screen 2002; 9(4): 187-190. (Pubitemid 36135347)
14. Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. BrJ Cancer 1999; 80 Suppl 1:95-103.
15. Office for National Statistics. Deaths by heal authority of usual residence, numbers and standardised mortality ratios (SMRs) by sex, 2006 registrations: Health Statistics Quarterly. http://www.statistics.gov.uk/ StatBase/ssdatasetasp?vlnk=9677&Pos =1&ColRank=2&Rank=272 (access 2 Jul 2010).
16. Boekholdt SM, Peters RJ, Day NE, et al. Macrophage migration inhibitory (actor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: The EPIC-Norfolk Prospective Population study. Am J Med 2004; 117(6): 390-397.
17. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study, Circulation 2008; 117(6): 743-753.
18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44(3): 837-845.
19. Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York, NY: John Wiley & Sons Inc, 1989.
20. Chamnan P, Simmons RK, Sharp SJ, et al. Cardiovascular risk assessment scores for people with diabetes: a systematic review. Diabetolagia 2009; 52(10): 2001-2014.
21. Collins GS, Airman DG. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ 2009; 339: b2584.
22. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97(18): 1837-1847.
23. Silventoinen K, Pankow J, Lindström J, et al. The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality. Eur J Cardiovasc Prev Rehabil 2005; 12(5): 451-458. (Pubitemid 44966789)
24. Marshall T, Rouse A. Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study. BMJ 2002; 325(7357): 197.
25. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008; 336(7659): 1475-1482. (Pubitemid 351977019)